In a surprising turn of events, Clearmind Medicine (NASDAQ: NASDAQ:CMND ) has witnessed a staggering 42% surge in its stock value following a groundbreaking meeting with the U.S. Food and Drug Administration (FDA). The company, which aims to revolutionize mental health treatment using psychedelics, appears to be at the forefront of a transformative trend...
